|
Download the program
|
|
9h00 |
Welcoming participants |
|
Renal explorations | Moderators: Dominique Eladari (Paris) - Franck Bienaimé Paris) |
9h30 | 1. Renal medulla. | Lise Bankir (Paris) |
10h15 | 2. In vivo microscopy. | Janos Peti-Peterdi (Los Angeles) |
10h45 | 3. Renal elasticity. | Jean-Michel Correas (Paris) |
11h10 | Pause | |
Progression and fibrosis. | Moderators: Guillaume Canaud (Paris) - Alexandre Hertig (Paris) |
11h30 | 4. Mécanismes. | Fabiola Terzi (Paris) |
12h00 | 5. Strétégie Anti-mir 21. | Jeremy S. Duffield (Seattle) |
12h30 | 6. De l'IRA à la MRC. | Joseph Bonventre (Boston) |
13h15 | Déjeuner | |
MRC in the general population. | Moderators: Christian Combe (Bordeaux) - Zohair Oualim (Rabat) |
14h00 | 7. CKD-Rein | Bénédicte Stengel (Paris) |
14h30 | 8. MaReMar | Marc De Broe (Gand) |
Glomerular nephropathies. | Moderators: Frank Martinez (Paris) - Vincent Audard (Créteil) |
15h00 | 9. Membranoproliferative Glomerulonephritis | Fadi Fakhouri (Nantes) |
15h30 | 10. Renal impairment of type 1 cryoglobulinemia | Mohamad Zaidan (Paris) |
16h00 | Pause | |
Symposium satellite : Amgen | Modérateur : Eric Thervet (Paris) |
| Management of lipid risk in patients with renal insufficiency | |
16h30 | Genetics to identify a new therapeutic target: history of PCSK 9 | Catherine Boileau (Paris) |
17h00 | The therapeutic strategy "lower is better" | Nicolas Danchin (Paris) |
17h30 | Prevention of lipid risk in IRC - treat or not? | Ziad Massy (Boulogne-Billancourt) |